Jazz Pharmaceuticals plc (JAZZ) /
The profitability of Jazz Pharmaceuticals plc over the past 10 years
Chart Jazz Pharmaceuticals plc: operating income, net income, fiscal 2016–2025 Open the chart →Jazz Pharmaceuticals plc reported a net loss of $356.15M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $430.24M. It reported a profit in 7 of the 10 years shown, and a loss in fiscal 2021, 2022 and 2025. Its highest net income in these years was $560.12M, in fiscal 2024.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$430.24M | -$356.15M |
| 2024ended Dec 31, 2024 | $716.63M | $560.12M |
| 2023ended Dec 31, 2023 | $578.58M | $414.83M |
| 2022ended Dec 31, 2022 | -$65.53M | -$224.06M |
| 2021ended Dec 31, 2021 | $170.28M | -$329.67M |
| 2020ended Dec 31, 2020 | $378.07M | $238.62M |
| 2019ended Dec 31, 2019 | $532.37M | $523.37M |
| 2018ended Dec 31, 2018 | $614.84M | $447.1M |
| 2017ended Dec 31, 2017 | $528.84M | $487.85M |
| 2016ended Dec 31, 2016 | $591.65M | $396.83M |
Fiscal years as Jazz Pharmaceuticals plc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Jazz Pharmaceuticals plc
- The revenue of Jazz Pharmaceuticals plc
- The cash flow of Jazz Pharmaceuticals plc
- The debt of Jazz Pharmaceuticals plc
- All of Jazz Pharmaceuticals plc's financials, charted
Companies of a similar size
- RBCRBC BEARINGS INCORPORATED
- NBIXNEUROCRINE BIOSCIENCES INC
- SWKSTANLEY BLACK & DECKER, INC.
- PFGCPerformance Food Group Company
- ULSUL Solutions Inc.
Not investment advice. This page shows what Jazz Pharmaceuticals plc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.